Effect of 5-aminolevulinic acid dose and estrogen on protoporphyrin IX concentrations in the rat uterus

Journal of the Society for Gynecologic Investigation

Volumn 4, Issue 1, 1997, Pages 40-46

  Roy, Brenda N ^b   Van Vugt, Dean A ^b   Weagle, Glenn E ^b   Pottier, Roy H ^b   Reid, Robert L ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b NONE

Author keywords

5 aminolevulinic acid; estrogen; Protoporphyrin IX; rat uterus

Indexed keywords

AMINOLEVULINIC ACID; ESTROGEN; PROTOPORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; MENORRHAGIA; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT;

AMINOLEVULINIC ACID; ANALYSIS OF VARIANCE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIUM; ESTRADIOL; FEMALE; MYOMETRIUM; PROTOPORPHYRINS; RATS; RATS, SPRAGUE-DAWLEY; UTERUS;

EID: 0031047262     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(96)00062-7     Document Type: Article

References (28)

1. 1. Wyss P, Tromberg BJ, Wyss MT, et al. Photodynamic destruction of endometrial tissue with topical 5-aminolevulinic acid in rats and rabbits. Am J Obstet Gynecol 1994;171:1176-83.
2. 2. Yang JZ, Van Vugt DA, Kennedy JC, Reid RL. Intrauterine 5-aminolevulinic acid induces selective fluorescence and photodynamic ablation of the rat endometrium. Photochem Photobiol 1993;57:803-7.
3. 3. Yang JZ, Van Vugt DA, Roy BN, Kennedy JC, Foster WG, Reid RL. Intrauterine 5-aminolevulinic acid induces selective endometrial fluorescence in the Rhesus monkey and Cynomolgus monkey. J Soc Gynecol Invest 1996;3:152-7.
4. 4. Gannon MJ, Johnson N, Roberts DJH, et al. Photosensitization of the endometrium with topical 5-aminolevulinic acid. Am J Obstet Gynecol 1995;173:1826-8.
5. 5. Yang JZ, Van Vugt DA, Melchoir MF, Hahn P, Reid RL. Photodynamic ablation of early pregnancy in the rat with 5-aminolevulinic acid: A potential new therapy for tubal ectopic pregnancy in the human. Fertil Steril 1994;62:1060-5.
6. 6. Stott PC. The outcome of menorrhagia: A retrospective case control study. J R Coll Gen Pract 1983;33:715-20.
7. 7. Pokras R, Hufnagel VG. Hysterectomy in the United States. Am J Public Health 1988;78:852-3.
8. 8. Jamieson MA, Reid RL. Compliance with menopausal hormone replacement therapy. In: Lorrain J, ed. Modern management and treatment of menopause and osteoporosis. 2nd ed. Montreal: Les Presses de l'Universite de Montreal, 1995:622-7.
9. 9. Hahn RG. Compliance considerations with estrogen replacement: Withdrawal bleeding and other factors. Am J Obstet Gynecol 1989;161:1854-8.
10. 10. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol 1992;55:145-57.
11. 11. Batlle AMd. Porphyrins, porphyrias, cancer and photodynamic therapy - a model for carcinogenesis. J Photochem Photobiol 1993;20:5-22.
12. 12. Kennedy JC, Pottier RH. Endogeneous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol 1992;14:275-92.
13. 13. Ash DV, Brown SB. New drugs and future developments in photodynamic therapy. Eur J Cancer 1993;29A:1781-3.
14. 14. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience. J Photochem Photobiol 1990;6:143-8.
15. 15. Loh CS, MacRobert AJ, Bedwell J, Regula J, Krasner N, Bown SG. Oral versus intravenous administration of 5-aminolevulinic acid for photodynamic therapy. Br J Cancer 1993;68:41-51.
16. 16. Yang JZ, Van Vugt DA, Kennedy JC, Reid RL. Evidence of lasting functional destruction of the rat endometrium after 5-aminolevulinic acid-induced photodynamic ablation: Prevention of implantation. Am J Obstet Gynecol 1993;168:995-1001.
17. 17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193: 265-75.
18. 18. MacRobert AJ, Bown SG, Philips D. What are the ideal photo-properties for a sensitizer? In: Bock G, Harnett S, eds. Photosensitizing compounds: Their chemistry, biology and clinical use. Toronto: John Wiley and Sons, 1989:4-16.
19. 19. Pottier RH, Chow YFA, LaPlante J-P, Truscott TG, Kennedy JC, Beiner LA. Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo. Photochem Photobiol 1986;44:679-87.
20. 20. Rossi F, Campbell D, Pottier RH, Kennedy JC, Dickson EF. In vitro studies on the potential use of 5-aminolevulinic acid-mediated photodynamic therapy for gynecologic tumors. Br J Cancer 1996;74:881-7.
21. 21. Judd MD, Bedwell J, MacRobert AJ, Bown SG. Comparison of the distribution of phthalocyanine and ALA-induced porphyrin sensitisers within the rabbit uterus. In: Spinelli P, Dal Fante M, Marchesini R, eds. Photodynamic therapy and biomedical lasers. New York: Elsevier Science Publishers, 1992:322-6.
22. 22. Iinuma S, Farshi SS, Ortel B, Hasan T. A mechanistic study of cellular photodestruction with 5-aminolevulinic acid-induced porphyrin. Br J Cancer 1994;70:21-8.
23. 23. Wyss P, Svaasand LO, Tadir Y, et al. Photomedicine of the endometrium: Experimental concepts. Hum Reprod 1995;10: 221-6.
24. 24. Lin MC, Gosink BB, Wolf SI, et al. Endometrial thickness after menopause: Effect of hormonal replacement. Radiology 1991; 180:427-32.
25. 25. Steinbach P, Weingandt H, Baumgartner R, Kriegmair M, Hofstadter F, Knuchel R. Cellular fluorescence of the endogenous photosensitizer protoporphyrin IX following exposure to 5-aminolevulinic acid. Photochem Photobiol 1995;62:887-95.
26. 26. Fukuda H, Batlle AMd, Riley PA. Kinetics of porphyrin accumulation in cultured epithelial cells exposed to 5-aminolevulinic acid. Int J Biochem 1993;25:1407-10.
27. 27. Goldrath MH, Fuller TA, Segal S. Laser photovaporization of endometrium for the treatment of menorrhagia. Am J Obstet Gynecol 1981;140:14-9.
28. 28. Lomano JM. Dragging technique versus blanching technique for endometrial ablation with the Nd: YAG laser in the treatment of chronic menorrhagia. Am J Obstet Gynecol 1988;159:152-5.